Clinical Trials on MACE in China

Total 867 results

InventisBio Co., Ltd

Active, not recruiting

A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553

Healthy Male

China
Peking University Third Hospital

Completed

Effect of Age on Sperm Recovery of Microdissection Testicular Sperm Extraction in Nonobstructive Azoospermia Patients

Non-obstructive Azoospermia

China
Peking University Third Hospital

Completed

Machine Learning Based-Personalized Prediction of Sperm Retrieval Success Rate

Infertility, Male | Azoospermia, Nonobstructive

China
3D Medicines (Sichuan) Co., Ltd.

Recruiting

Phase I Trial of Envafolimab for Healthy Male Subjects

Healthy Male

China
Shanghai Henlius Biotech

Completed

Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects

Healthy Male Volunteers

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Bioequivalence Study of Tafolecimab Injections in Chinese Healthy Male Volunteers

Healthy Male Subjects

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Mass Balance and Biotransformation Study of [14C]DBPR108 in Human

Healthy Male Subjects

China
Jinling Hospital, China

Recruiting

Omega-3 PUFA for Treatment of Patients With Idiopathic Oligoasthenoteratospermia

Male Infertility Due to Hypospermatogenesis

China
Shanghai Henlius Biotech

Recruiting

A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects

Healthy Male Volunteers

China
Sunshine Lake Pharma Co., Ltd.

Completed

ADME Study of [14C] Yiqibuvir in Healthy Male Subjects

Healthy Male Subjects

China
Otsuka Beijing Research Institute

Completed

OPC-61815 in Healthy Chinese Male Subjects

Healthy Adult Male

China
Sunshine Lake Pharma Co., Ltd.

Completed

ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects

Healthy Male Subjects

China
Vigonvita Life Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Completed

Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects

Healthy Male Subjects

China
Xuanzhu Biopharmaceutical Co., Ltd.

Not yet recruiting

A Clinical Trial of XZP-3287 for Material Balance

Healthy Male Subjects

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Mass Balance and Biotransformation Study of [14C]SKLB1028 in Chinese Healthy Male Subjects

Healthy Male Subjects

China
UCB Biopharma S.P.R.L.

Completed

A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects

Healthy Male Volunteers

China
UCB Biopharma S.P.R.L.

Completed

A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male Subjects

Healthy Male Chinese Volunteers

China
Shanghai Institute Of Biological Products

Completed

A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects

Healthy Male

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Not yet recruiting

The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028

Healthy Male Volunteers

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man

Healthy Male Adult

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Completed

The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers

Healthy Male Volunteers

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on Fluzoparib

Healthy Male Subjects

China
Akeso

Completed

A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects

Healthy Male Subjects

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Drug Interaction Between SHR4640 Tablets and Furosemide Tablets in Healthy Volunteers (Single Center, Single Arm, Open, Self-control)

Healthy Male Subjects

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects

Healthy Male Subjects

China
Shanghai Henlius Biotech

Completed

Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX04 Versus Avastin® in Healthy Male Subjects

Healthy Male Subjects

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Relative Bioavailability Study of SHR3680 (SHR-3680)

Healthy Male Subjects

China
Allist Pharmaceuticals, Inc.

Completed

Study Evaluating the Mass Balance And Biotransformation of Single Dose[14C] AST2818 in Chinese Healthy Male Volunteers

Healthy Male Volunteers

China
Changhai Hospital

Recruiting

Adjuvant Hypofractionated Radiotherapy for Prostate Cancer

Prostate Cancer

China
Bivision Pharmaceuticals, Inc.

Recruiting

Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer

Prostate Cancer

China
Peking University First Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaborators

Recruiting

A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer

Prostate Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

the Beijing Randomized Study Of Prostate Cancer Screening (BROPCS)

Prostate Cancer

China
Shanghai East Hospital
Peking Union Medical College Hospital; Qilu Hospital of Shandong University; Shandong... and other collaborators

Not yet recruiting

Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy

Prostate Cancer

China
Peking University Cancer Hospital & Institute

Active, not recruiting

[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients

Prostate Cancer

China
Shanghai East Hospital

Not yet recruiting

Multi-Modal Image Fusion for Precision Prostate Biopsy Navigation

Prostate Cancer

China
Peking University First Hospital

Recruiting

Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial

Prostate Cancer

China
Hinova Pharmaceuticals Inc.

Recruiting

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC).

mCRPC

China
Bio-Thera Solutions
Wuhan Union Hospital, China

Active, not recruiting

Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects

Healthy Male Subjects

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants

Healthy Male Volunteers

China
Shanghai Henlius Biotech

Completed

Compare Pharmacokinetics, Safety, and Immunogenicity of HLX11 vs. Perjeta in Healthy Chinese Male Subjects

Healthy Male Volunteers

China
Shanghai Henlius Biotech

Terminated

Compare Pharmacokinetic, Safety, Tolerability and Immunogenicity of HLX12 and Ramucirumab in Healthy Male Adult Subjects

Healthy Male Volunteers

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects

Healthy Male Subjects

China
Jiangsu vcare pharmaceutical technology co., LTD

Completed

The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man

Healthy Male Adult

China
Allist Pharmaceuticals, Inc.

Completed

Study to Determine the Effect of Food on the Blood Levels of AST2818 Following Single Oral Doses in Healthy Male Volunteers

Healthy Male Volunteers

China
Peking University Third Hospital
Bayer

Not yet recruiting

Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study

Prostate Cancer

China
Peking University First Hospital

Recruiting

Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis

Prostate Cancer

China
HTA Co., Ltd.

Recruiting

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

Prostate Cancer

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

Prostate Cancer

China
Nova Therapeutics LLC
Chinese PLA General Hospital

Recruiting

CART-PSMA Cells for Advanced Prostate Cancer

Prostate Cancer

China
Peking University Cancer Hospital & Institute

Active, not recruiting

PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer

Prostate Cancer

China

3

Subscribe